Proliferative Diabetic Retinopathy (PDR) Completed Phase 2 / 3 Trials for Aflibercept (DB08885)
Also known as: PDR - Proliferative Diabetic Retinopathy / Diabetic Proliferative Retinopathy / Proliferative Diabetic Retinopathy / Proliferative retinopathy due to diabetes mellitus (disorder) / Retinopathy due to diabetes mellitus (disorder) / Diabetic retinopathy / Retinopathy diabetic
Indication | Status | Phase |
---|---|---|
DBCOND0056889 (Proliferative Diabetic Retinopathy (PDR)) | Completed | 2 / 3 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT01813773 | Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study | Treatment | |
NCT02858076 | Anti-VEGF vs. Prompt Vitrectomy for VH From PDR | Treatment |